FDA says it wants a more predictable PMTA process. That’s welcome news for an industry that has spent years navigating shifting standards, mass denials and regulatory limbo. But will it deliver?

In this episode of RegWatch, Tony Abboud of the Vapor Technology Association takes us inside the push for reform, from the campaign to save flavored vaping to the case for clear scientific standards. Abboud explains what a workable pathway could mean for American businesses and why the fight is far from over.

What will replace the broken rule, and will it be enough to save vaping?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: Nov 4, 2026
Produced by: Brent Stafford

This episode is supported by Mi-Pod Wholesale

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

Devin Gusich helps U.S. vape businesses navigate a regulatory labyrinth that can leave even their lawyers searching for answers.

As Mi-Pod’s first employee and now director of business development, he draws on 18 years of experience and close customer relationships to explain what it takes to serve adult smokers in this environment.

From threatening letters to pressure on shipping, payment processing and online sales, Gusich describes what he sees as Big Tobacco’s campaign to bleed vape businesses dry. He explains the toll on the companies that built the industry and why their call for clear, workable regulation is rooted in a determination to keep helping smokers quit.

Watch RegWatch Special Coverage “Inside U.S. Vaping.”

On location at Mi-Pod Wholesale in Phoenix, Arizona.

Part 2 of 3 – BLEED US DRY | Vape Veteran on Big Tobacco’s Campaign to Crush Vaping

Only on RegWatch by RegulatorWatch.com.

Released: November 1, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

Rebecca Basinski offers an inside look at what it takes to keep a U.S. vaping business operating amid unclear federal rules, conflicting state restrictions and pressure on the companies it relies upon. As Mi-Pod’s vice president of finance and accounting, with responsibility for compliance, she deals directly with the financial and operational consequences of that uncertainty.

From a crisis that nearly bankrupted the company to legal battles over the products it sells, Basinski describes the challenges facing a business determined to serve adult consumers. She explains why clear rules matter to the people building the industry and why she believes it has a future worth fighting for.

Watch RegWatch Special Coverage “Inside U.S. Vaping.”

On location at Mi-Pod Wholesale in Phoenix, Arizona.

Part 1 of 3 — NO CLEAR RULES | Mi-Pod’s Finance Chief on Uncertainty Facing U.S. Vaping

Only on RegWatch by RegulatorWatch.com.

Released: October 28, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

While FDA and its Center for Tobacco Products are beginning to acknowledge Americans badly misunderstand the relative risks of nicotine vaping products compared with cigarettes, recent research out of UT Southwestern Medical Center identifies FDA’s own Real Cost campaign “An Epidemic Is Spreading” as a significant contributor to that collapse in public understanding.

The U.S. study found that 30% of adults surveyed now believe nicotine vapes are more harmful than cigarettes, a more than tenfold increase, while the proportion who correctly recognized vaping as less harmful than smoking collapsed from half of U.S. adults to just 17%.

In this episode of RegWatch, study author Dr. Alexander Wu and lung cancer specialist Dr. David Gerber examine the dramatic reversal in public perception and the consequences for adult smokers.

Researchers found statistically significant shifts associated with FDA’s Real Cost campaign and the 2019 EVALI outbreak. Following these major events, more Americans became afraid of vaping and less afraid of smoking.

The same disturbing trend appeared across age, sex, race, ethnicity, and smoking status. And while FDA’s campaign was aimed at youth, the study documented the deterioration in public understanding among American adults.

Gerber says it may now be time for health professionals and public health communities to intervene and correct these dangerous misperceptions.

Did FDA help create the public health crisis it now says must be fixed?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: October 17, 2026
Produced by: Brent Stafford

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

The U.S. vaping industry is on the cusp of monumental change. Following detailed reports by the Wall Street Journal and Reuters, FDA has formally announced its intention to evaluate a possible overhaul of the PMTA framework, including new rulemaking to replace the existing system.

In this episode of RegWatch, tobacco control policy expert Cliff Douglas examines the developments driving the shift: mounting legal pressure, new CTP Director Bret Koplow’s embrace of harm reduction, and FDA commissioner nominee Dr. Heidi Overton’s defense of flavored vape authorizations.

With youth vaping sharply down and an enormous illicit market operating outside FDA oversight, the case for change is hard to ignore. But Douglas warns that faster approvals alone won’t help smokers who still misunderstand the risks of safer nicotine.

Is FDA about to rewrite the rules governing nicotine vapes?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: October 7, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

#RegWatch #VapeNews

For nearly a decade, the U.S. vaping community has called the FDA’s campaign against nicotine vapes a war on vaping.

Beginning with the deeming rule, the agency’s aggressive action against Juul, the so-called teen-vaping epidemic, the “Real Cost” campaign, the denial of millions of PMTA applications, and FDA’s steadfast refusal to counter misinformation and set the record straight on the relative risks and benefits of vaping versus smoking—it certainly feels like a war. But is it?

In this episode of RegWatch, Dr. Raymond March, Director of FDAReview.org and Research Fellow at the Independent Institute, says: “Oh, absolutely. It might be the biggest war the FDA has waged.”

March argues FDA regulation has protected Big Tobacco, enabled selective enforcement, and distorted public understanding of relative risk. Rather than protecting public health, he says the agency’s approach has been self-serving, politically malleable, and extraordinarily destructive.

Could the FDA be winning its war on vaping, or is the war finally nearing its end?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: September 9, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign

GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

After years of bruising court battles, the U.S. vaping industry has finally scored a major win against the U.S. Food & Drug Administration.

The Fifth Circuit ruled this week that FDA violated the Administrative Procedure Act when it imposed its comparative-efficacy standard without notice-and-comment rulemaking. FDA used that standard to issue more than one million marketing denial orders, producing what the court calls a “de facto ban” on nicotine-vape flavors other than tobacco.

In this breaking-news episode of RegWatch, Keller and Heckman attorney Eric P. Gotting, who represented NicQuid and argued the case, explains why the court vacated the MDOs and sent the applications back to FDA.

If the ruling sticks, could it dismantle FDA’s mass-denial system for flavored vapes and finally provide relief to the entire industry?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: Aug 22, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser

For years, the U.S. vaping industry played defense against fear-driven headlines, political pressure campaigns, flavor bans, and state registry bills designed to eliminate nearly every nicotine vaping product from the legal market.

But now, some industry leaders say it’s time to play offense.

In this wide-ranging RegWatch interview, Geoff Habicht, President and Co-Founder of Mi-One Brands, explains how the vaping industry helped craft a new regulatory framework in Arizona that strengthens youth-access enforcement, recognizes responsible businesses, and targets genuine bad actors.

He challenges the misleading use of the term “illicit,” considering many of the best-known vaping products sold by independent retailers have entered the FDA’s premarket review process and may remain on the market under the agency’s new enforcement guidance.

He also breaks down Shopify’s disastrous decision to pull the plug on U.S. vape retailers.

Can the vaping industry move beyond playing defense and change the way America sees vaping?

Find out. Only on RegWatch by RegulatorWatch.com.

Released: Aug 11, 2026
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.

CELEBRATE WITH US | RegWatch 10th Anniversary Fundraising Campaign
GoFundMe: https://www.gofundme.com/f/regwatch-10th-anniversary-fundraiser